BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35778377)

  • 1. Diffuse spinal cord metastasis after resection of SMARCB1 sinonasal carcinoma manifesting with a right foot drop-a case report.
    da Silva MA; Bentes RGL; Teixeira HS; Carvalho BM; Queiroz ALG; Schmid MF; Lima KDF; Ferreira WSM; Campos CMS; Neto MR; Baeta AM
    Spinal Cord Ser Cases; 2022 Jul; 8(1):64. PubMed ID: 35778377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
    Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
    Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCA4-deficient Sinonasal Carcinoma.
    Agaimy A; Weichert W
    Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
    Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
    Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.
    Gomez-Acevedo H; Patterson JD; Sardar S; Gokden M; Das BC; Ussery DW; Rodriguez A
    BMC Cancer; 2019 Aug; 19(1):827. PubMed ID: 31438887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
    Trieu V; Aulet RM; Ciolino A; Rimash T
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
    Allison DB; Bishop JA; Ali SZ
    Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
    Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
    Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCB1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
    Parsel SM; Jawad BA; McCoul ED
    World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
    McHugh KE; Policarpio-Nicolas MLC
    Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
    Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
    Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature.
    AlMadan NM; AlEssa EA; AlGhamdi DA
    Am J Case Rep; 2023 May; 24():e939244. PubMed ID: 37198880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinonasal SMARCB1 (INI1) Deficient Carcinoma With Yolk Sac Tumor Differentiation: Report of a Case and Comparison With INI1 Expression in Gonadal Germ Cell Tumors.
    Zamecnik M; Rychnovsky J; Syrovatka J
    Int J Surg Pathol; 2018 May; 26(3):245-249. PubMed ID: 29166820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
    Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
    Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1(INI1)-deficient sinonasal adenocarcinoma: Report of a case previously diagnosed as high-grade non-intestinal-type sinonasal adenocarcinoma.
    Su YJ; Lee YH; Hsieh MS
    Pathol Int; 2022 Jan; 72(1):53-58. PubMed ID: 34597447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
    Agaimy A
    Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
    Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
    J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
    Kezlarian BE; Lin O; Dogan S
    J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.